Digital Pathology Podcast

190: Can a Better Stain Improve AI in Pathology?


Listen Later

Send us Fan Mail

What if one of the biggest sources of diagnostic variability in prostate cancer isn’t the pathologist—but the stain we’ve trusted for decades?

In this episode, I speak with Professor Ingid Carlbom, founder of CADESS.AI, about a different way to approach prostate cancer grading—by rethinking staining, segmentation, and AI decision support from the ground up. We explore why 30–40% interobserver variability persists in Gleason grading and how optimized stains combined with explainable AI can significantly reduce that uncertainty.

Ingrid shares her journey from applied mathematics and computer science into pathology, the skepticism she faced in 2008, and why CADESS.AI chose not to “optimize H&E,” but instead developed a Picrosirius red + hematoxylin stain designed specifically for computational pathology. We discuss how grading at the gland and cellular level improves reproducibility, why explainability matters for trust, and what it really takes to build both stain and software as a single diagnostic workflow.

This conversation challenges long-held assumptions—and asks whether improving data quality should come before building smarter algorithms.


Highlights:

  • [00:00–01:08] The problem: 30–40% disagreement in prostate cancer grading
  • [01:08–03:03] Ingrid’s path from applied math to digital pathology
  • [03:03–04:58] Early skepticism toward AI in pathology and fear of replacement
  • [04:58–08:56] Why H&E limits segmentation—and how a new stain changes that
  • [10:55–15:09] Clinical testing: non-inferiority, AI assistance, and NCCN risk stratification
  • [19:47–22:59] Explainable UI: color-coded glands and pathologist override
  • [26:16–27:29] Why grading glands (not whole slides) reduces variability
  • [38:09–41:47] Regulatory challenges of combined stain + AI devices
  • [45:52–48:55] The future of optimized stains in routine pathology


Resources from This Episode

  • CADESS.AI – Prostate cancer decision support system
  • NCCN prostate cancer risk stratification guidelines

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!

...more
View all episodesView all episodes
Download on the App Store

Digital Pathology PodcastBy Aleksandra Zuraw, DVM, PhD

  • 5
  • 5
  • 5
  • 5
  • 5

5

7 ratings


More shows like Digital Pathology Podcast

View all
NEJM This Week by NEJM Group

NEJM This Week

321 Listeners

NEJM Interviews by NEJM Group

NEJM Interviews

124 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

504 Listeners

Nature Podcast by Springer Nature Limited

Nature Podcast

756 Listeners

Talk Python To Me by Michael Kennedy

Talk Python To Me

583 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

818 Listeners

Super Data Science: ML & AI Podcast with Jon Krohn by Jon Krohn

Super Data Science: ML & AI Podcast with Jon Krohn

306 Listeners

NVIDIA AI Podcast by NVIDIA

NVIDIA AI Podcast

343 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

125 Listeners

The Readout Loud by STAT

The Readout Loud

337 Listeners

Yale Cancer Answers by Dr. Eric P. Winer

Yale Cancer Answers

21 Listeners

Zero to Finals Medical Revision Podcast by Thomas Watchman

Zero to Finals Medical Revision Podcast

141 Listeners

Harrison's PodClass: Internal Medicine Cases and Board Prep by AccessMedicine

Harrison's PodClass: Internal Medicine Cases and Board Prep

367 Listeners

Lab Medicine Rounds by Mayo Clinic Laboratories

Lab Medicine Rounds

16 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

152 Listeners